
Adult-Use
Europe Just Months Away From ‘Recreational Cannabis Domino Effect’, Says Curaleaf Chief
CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in

CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in

FOLLOWING its recent purchase of UK cannabis firm EMMAC Life Sciences, Curaleaf has now secured an additional $130m from a

EMMAC CEO Antonio Costanzo believes its purchase by US and global leader Curaleaf is a signal to Europe’s politicians that